Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Sebela Pharmaceuticals Inc. 401(K) Plan is a benefit plan reported by Braintree Laboratories, Inc. under EIN 04-2769947 and plan number 001. The latest loaded filing year is 2023. The filing reports 474 participants and $67,842,645 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $67,842,645
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $67,842,645
- Net assets (BOY)
- $53,839,579
Income & contributions
- Employer contributions
- $1,226,795
- Participant contributions
- $3,427,012
- Total contributions
- $5,735,564
- Total income / additions
- $16,769,648
Expenses & distributions
- Benefits paid
- $2,709,568
- Administrative expenses
- $57,014
- Total expenses
- $2,766,582
- Net increase / (decrease)
- $14,003,066